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Mycobacterium tuberculosis persists within macro-
phages in an arrested phagosome and depends
upon necrosis to elude immunity and disseminate.
Although apoptosis of M. tuberculosis-infected
macrophages is associated with reduced bacterial
growth, the bacteria are relatively resistant to other
forms of death, leaving the mechanism underlying
this observation unresolved. We find that after apo-
ptosis, M. tuberculosis-infected macrophages are
rapidly taken up by uninfected macrophages through
efferocytosis, a dedicated apoptotic cell engulfment
process. Efferocytosis of M. tuberculosis seques-
tered within an apoptotic macrophage further com-
partmentalizes the bacterium and delivers it along
with the apoptotic cell debris to the lysosomal com-
partment.M. tuberculosis is killed only after efferocy-
tosis, indicating that apoptosis itself is not intrinsically
bactericidal but requires subsequent phagocytic
uptake and lysosomal fusion of the apoptotic body
harboring thebacterium.While efferocytosis is recog-
nized as a constitutive housekeeping function of
macrophages, these data indicate that it can also
function as an antimicrobial effector mechanism.
INTRODUCTION
Cell death frequently occurs after intracellular infection, and
many pathogens target cell death pathways as a virulence
strategy (Faherty and Maurelli, 2008). After infection of macro-
phages (M4s) by Mycobacterium tuberculosis (Mtb), the caus-
ative agent of tuberculosis, the bacilli persist within arrested,
immature phagosomes. A strategy for Mtb virulence is the
induction of necrosis, which enables the bacterium to evade
host defenses, disperse, and infect surrounding macrophages
(Keane et al., 2000). In contrast, attenuated Mtb strains and
mutants lacking key virulence factors induce far less necrosis
and instead stimulate apoptosis (Chen et al., 2006; Miller
et al., 2010). Apoptosis of Mtb-infected macrophages is asso-Cell Host & Mciated with reduced bacterial growth (Molloy et al., 1994;
Oddo et al., 1998). While it is assumed that apoptosis is in-
trinsically bactericidal, there is little evidence to support this
assertion. In fact, as Mtb emerges unscathed after necrotic
cell death, it seems unlikely that apoptosis could harm the
bacterium.
As cells undergo apoptosis, they emit ‘‘find me’’ signals such
as ATP to attract circulating phagocytes (Elliott et al., 2009;
Hume, 2008; Kono and Rock, 2008). Additionally, the dying cells
expose ‘‘eat me’’ signals on their surface, such as phosphatidyl-
serine (PS). Responding phagocytes, predominantly macro-
phages, employ a variety of surface receptors to bind these
‘‘eat me’’ signals, and mediate the recognition, tethering, and
engulfment of apoptotic cells (Erwig and Henson, 2008; Zhou
and Yu, 2008). This process of apoptotic cell engulfment, called
efferocytosis, is distinct from phagocytosis and is crucial for
organogenesis and the resolution of inflammation (Kinchen and
Ravichandran, 2010). If apoptotic cells are not cleared by effer-
ocytosis, they undergo secondary necrosis in which inflam-
matory cellular contents leak into the extracellular space,
contributing to autoimmunity and persistent inflammation
(Fernandez-Boyanapalli et al., 2010; Peng and Elkon, 2011).
Despite the substantive cell death that accompanies infection,
the role of efferocytosis during infection, particularly with respect
to efferocytosis of infected cells, has not been thoroughly
investigated. Based on the known association between macro-
phage apoptosis and host resistance to Mtb, we hypothesized
that the antibacterial role of apoptosis is mediated through
efferocytosis.
We report here that efferocytosis of Mtb-infected macro-
phages occurs in vitro and in vivo. Apoptosis itself is not intrin-
sically bactericidal; instead, efferocytosis is required to
mediate control of the bacterium after apoptosis. We find
that the efferocytic phagosome containing Mtb readily fuses
with lysosomes and that this leads to bacterial killing both
in vitro and in vivo. We speculate that engulfed Mtb confined
within an apoptotic cell further compartmentalizes the bacte-
rium and prevents its virulence factors from interfering with
phagosome maturation. Thus, efferocytosed Mtb is destroyed
along with the apoptotic cell debris. Efferocytosis has long
been known to be a crucial macrophage function, but we
report here that efferocytosis is also an innate immune effector
function.icrobe 12, 289–300, September 13, 2012 ª2012 Elsevier Inc. 289
bt
M
L
E
N
UT
A
N
D
merge
0
5
10
15
20
%
+bt
M/+L
E
N
UT
* *
caspase inhibited
- ctrl 3 8 9
0.0
0.5
1.0
1.5
2.0
caspase inhibited
ne
cr
os
is
 (r
el
at
iv
e 
va
lu
e)
3 8 9
A B C
* *
Figure 1. Mtb-Infected Macrophages
Undergo Apoptosis
(A) Epifluorescence microscopy image of apo-
ptotic Mtb-infected CD11b+ thioglycollate-elicited
peritoneal macrophage (pM4). Mtb (red), TUNEL
(green), DNA (UV/pseudocolor blue), and merge.
(B) TUNEL+ Mtb-infected pM4s as a percent of
total infected pM4s 2 days after infection in the
presence of 10 mM caspase inhibitors or control
peptide, ctrl. Red dashed line is the mean percent
TUNEL+ of uninfected pM4s.
(C) Cell Death ELISA assay for necrosis 2 days
after Mtb infection of pM4s in the presence of
10 mM caspase inhibitors relative to infected
control-treated pM4s. Data are representative of
at least three experiments. One-way ANOVA with
Dunnet’s posttest.
*p < 0.05. Error bars indicate the mean ± SEM.
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Mtb-Infected Macrophages Undergo Apoptosis and Are
Engulfed by Uninfected Macrophages
While virulent Mtb predominantly induces necrosis of both
human and murine macrophages in vitro, particularly after
several days or at highmultiplicity of infection (MOI), careful anal-
ysis revealed that a spectrum of cell death modalities are
observed, including apoptosis (Danelishvili et al., 2003; Divan-
gahi et al., 2009; Duan et al., 2002). Thioglycollate-elicited peri-
toneal macrophages were infected with mCherry-expressing
H37Rv, resulting in the majority of macrophages harboring one
to five bacteria. Two days after infection, 15%of infectedmacro-
phages were apoptotic as determined by TdT-mediated d-UTP
nick end labeling (TUNEL) (Figures 1A and 1B). Under these
conditions, we found that apoptosis is triggered via the intrinsic
apoptosis pathway, depending predominantly on caspases 9
and 3 as inhibition of these caspases reduced the incidence
of TUNEL+ nuclei and subsequently drove more cells toward
necrosis (Figure 1C). There was not significant bystander
apoptosis of uninfectedmacrophageswithin the infectedmacro-
phage conditions (data not shown). Thus, a significant popula-
tion of H37Rv-infected macrophages undergoes apoptosis.
Phagocytes rapidly clear dying cells in vivo; however, whether
Mtb-infected apoptotic cells are engulfed by macrophages has
not been systematically addressed. We observed TUNEL+
nuclei contained within healthy, intact macrophages, indicating
that Mtb-infected apoptotic cells could be engulfed by other
macrophages (data not shown). To formally study efferocytosis
of Mtb-infected macrophages, we developed a confocal micros-
copy assay to monitor the fate of infected macrophages after
they die and are engulfed by neighboring macrophages (Fig-
ure 2A). Macrophages from C57Bl/6 mice, which express the
CD45.2 allele (hereafter referred to as CD45.2 macrophages),
were labeled with DiO and infected with mCherry-H37Rv
before addition of uninfected congenic CD45.1 macrophages.
Under these conditions, there was no discernible transfer of
dye between the macrophage membranes and bacterial mem-
branes (data not shown). There exist three predicted scenarios
after overnight coculture. First, Mtb can remain within the first
cell it infects—a primary infected cell (Figure 2Ai). Second,
necrosis of an infected macrophage allows Mtb to disperse290 Cell Host & Microbe 12, 289–300, September 13, 2012 ª2012 Elinto the culture supernatant and to infect other macrophages
(Figure 2Aii). These are secondarily infected macrophages.
Third, an adjacent CD45.1 macrophage could engulf an Mtb-
infected apoptotic macrophage (Figure 2Aiii). This is efferocyto-
sis. One day after coculture of infected and uninfected macro-
phages, all three scenarios were observed (Figure 2B). The
majority of Mtb were within primary infected macrophages.
However, 21.7% ± 1.7% of Mtb were within efferocytic
cells, and 9.8% ± 1.2% spread into secondarily infected cells
(mean ± SEM; n = 12 experiments). Secondarily infected cells
and efferocytic cells are distinguished based on whether or not
Mtb colocalizes within discrete DiO+ vesicles within a CD45.1
macrophage. This analysis may underestimate the frequency
of efferocytosis if the DiO label is degraded. The DiO signal did
not appear to decay within the first 24 hr of coculture, the time
point chosen for these experiments, although loss of signal
was observed after 48 hr. Additionally, secondary infectionmight
be overestimated, as not all extracellular Mtb can be re-
moved prior to the addition of uninfected macrophages, even
by extensive washing. Efferocytosis was observed with thiogly-
collate-elicited peritoneal macrophages, bone marrow-derived
macrophages, human peripheral blood monocyte-derived mac-
rophages, and resident peritoneal macrophages (Figures 2C and
2D and Figure S1A available online).We also consideredwhether
Mtb infection could inhibit efferocytosis. Uninfected and infected
macrophages similarly engulfed apoptotic thymocytes, indi-
cating that Mtb does not inhibit efferocytosis (Figure S1B).
Thus, by using a microscopy based coculture assay, we de-
tected significant efferocytosis of Mtb infected macrophages
in vitro.
Efferocytosis of Mtb-Infected Macrophages Occurs
in the Lung
For determination of whether efferocytosis of Mtb-infected cells
occurs in vivo, mCherry-H37Rv infected DiO-labeled CD45.2
macrophages were transferred intratracheally into the lungs of
CD45.1 congenic mice. Sixteen hours later, the airways of recip-
ient mice were lavaged, stained with antibodies directed against
CD45.1, and inspected by confocal microscopy (Figure S1C). All
three scenarios observed in vitro (Figure 2A) were observed
ex vivo. Recipient alveolar cells contained Mtb together with
the remnants of the primary infected macrophages (Figure 2E).sevier Inc.
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Figure 2. Efferocytosis of Mtb-Infected Apoptotic Macrophages In Vitro and In Vivo
(A) Assay for detecting efferocytosis of Mtb-infected apoptotic cells in vitro by confocal microscopy and its three predicted outcomes.
(B) Confocal microscopy images of CD45.2+ pM4s dyed with DiO, infected with mCherry-H37Rv and cocultured with uninfected undyed CD45.1+ pM4s for 16 hr
before fixation and visualization. Depicted are the three predicted outcomes of the efferocytosis assay: primary infection (i), secondary infection (ii), and
efferocytosis (iii).
(C) Efferocytosis seen using the above assay performed with bone marrow-derived macrophages (BMDM4s). Images are representative of more than 20
experiments.
(D) Efferocytosis seen after mCherry-H37Rv infection of DiO-dyed monocyte-derived human macrophages (hMDM4s) and coculture of uninfected Dextran-649
labeled hMDM4s.
(E) Representative images of recovered cells after bronchial alveolar lavage (BAL) 16 hr after transfer of infected pM4s. Images are representative of two
experiments.
See also Figure S1.
Cell Host & Microbe
Efferocytosis Is an Antibacterial Mechanism
Cell Host & Microbe 12, 289–300, September 13, 2012 ª2012 Elsevier Inc. 291
A infected Mφs alone+ uninfected Mφs
8
0
5
10
15
20
)
01
x(
UF
C
4
0 2 4 6
day
0
5
10
15
20
)
01
x(
UF
C
4
0 2 4 6 8
day
* *
H37Rv H37Ra
B
0
20
40
60 *
d0
+uninf. Mφs: - - +
C
FU
 ( 
x 
10
  )4
RAW264.7 Mφ 
d5
0
20
40
60
80
*
+uninf. Mφs: - - +
A3.1A7 BMDMφ 
C
FU
 ( 
x 
10
  )4
d0 d4
0
5
10
15 ***
C
FU
 ( 
x 
10
  )5
d0
+uninf. Mφs: - - +
d5
aMφ
0
5
10
15
20 *
+uninf. Mφs: - - +
d0 d4
C
FU
 ( 
x 
10
  )4
rMφC
D E
Figure 3. Uninfected Macrophage Coculture Limits Bacterial
Growth
(A) pM4s were infected with a 10:1 MOI of H37Rv (left) or H37Ra (right) for
4 hours before uninternalized bacteria were washed away and uninfected
pM4s were added at a ratio of 2:1. Bacterial burden was assessed by CFU
enumeration by plating serial dilutions of each condition in quadruplicate at the
indicated time points. Data are representative of more than 20 experiments
(H37Rv) and three experiments (H37Ra).
(B) Alveolar M4s (aM4s) were infected with an MOI of 10:1 H37Rv for 4 hr
before the addition of uninfected aM4s (+unif. M4s). CFU was enumerated
as described on days 0 (d0) and 5 (d5). Data are representative of two
experiments.
(C) Resident peritoneal M4s (rM4s) were infected as described with H37Rv
before the addition of uninfected rM4s and CFU enumeration on indicated
days. Data are representative of three experiments.
(D) RAW264.7 M4s were infected with H37Rv as previously described prior to
the addition of uninfected M4s of the same type. CFU was determined. Data
are representative of two experiments.
(E) A3.1A7 M4s were infected with H37Rv as previously described prior to the
addition of uninfected M4s of the same type. Data are representative of two
experiments.
Error bars indicate ± SEM, p% 0.05, Student’s t test.
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292 Cell Host & Microbe 12, 289–300, September 13, 2012 ª2012 ElSimilar results were seen after the intraperitoneal transfer of DiO-
dyed CD45.2 mCherry-H37Rv-infected macrophages into
CD45.1 recipient mice (data not shown). These results indicate
that efferocytosis of infected cells is a general phenomenon
that can be mediated by macrophages in different anatomical
compartments. Importantly, alveolar macrophages are capable
of engulfing Mtb-infected apoptotic macrophages and efferocy-
tosis of Mtb-infected macrophages occurs in the lung.
Conditions that Favor Efferocytosis RestrictMtbGrowth
A substantial number of primary infected macrophages under-
went apoptosis and the bacteria in these dying cells were en-
gulfed along with cell debris by other macrophages in the assays
described above. To determine whether the conditions in which
we observed efferocytosis affects bacterial viability, we cocul-
tured uninfected peritoneal macrophages with Mtb-infected
peritoneal macrophages and subsequently measured colony
forming units (CFU). The coculture of uninfected macrophages
with virulent H37Rv- or avirulent H37Ra-infected macrophages
significantly suppressed bacterial growth (Figure 3A). This anti-
bacterial activity was a feature of all types of macrophages
tested, including thioglycollate-elicited peritoneal macrophages,
alveolar macrophages (Figure 3B), resident peritoneal macro-
phages (Figure 3C), RAW264 cells (Figure 3D), and the A3.1A7
bone marrow-derived macrophage cell line (Figure 3E). Thus,
under conditions in which we detect efferocytosis by micros-
copy, bacterial growth is restricted.
Efferocytosis of Mtb-Infected Apoptotic Macrophages
Controls Mtb Growth
To prove that efferocytosis is responsible for the bacterial control
observed and not other contact-dependent or -independent
mechanisms, we sought to block efferocytosis itself. As effero-
cytosis requires the specific recognition and engulfment of
apoptotic cells, we predicted that inhibition of apoptosis by
caspase inhibitors would prevent efferocytosis and abrogate
the CFU reduction mediated by uninfected macrophages.
Conversely, if bacterial control by uninfectedmacrophage cocul-
ture were independent of apoptosis, caspase inhibition would
have no effect on Mtb growth. As predicted, inhibition of the
intrinsic apoptosis pathway (caspase 9-dependent), but not
the extrinsic pathway (caspase-8 dependent), reduced efferocy-
tosis of Mtb-infected macrophages by uninfected macrophages
as determined by confocal microscopy (Figure 4A). Similarly,
caspase 3 and 9 inhibition abrogated CFU control observed after
coculture of infected and uninfected macrophages (Figure 4B).
Caspase inhibition of infected macrophages, in the absence of
uninfected macrophages, had no effect on bacterial growth.
Thus, apoptosis is a prerequisite for restricting Mtb replication
in our macrophage coculture model.
To prove that efferocytosis was required for bacterial growth
restriction, we sought to inhibit the engulfment process itself.
Most macrophages express a variety of redundant receptors
that mediate the recognition and uptake of apoptotic cells (Elliott
and Ravichandran, 2010) and inhibition of any individual receptor
yielded little or no inhibition of apoptotic thymocyte uptake by
thioglycolate-elicited peritoneal macrophages in a noninfectious
model of efferocytosis (data not shown). An early event during
apoptosis is PS flipping to the outer leaflet of the plasmasevier Inc.
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Figure 4. Efferocytosis Controls Mtb Growth
(A) pM4s were infected as described in the confocal microscopy efferocytosis assay in the presence of 10 mMcaspase inhibitors. Percent efferocytosis is defined
as the number of M4s containing efferocytosed Mtb as a percent of total infected M4s. Data are representative of three experiments.
(B) pM4s were infected as described in Figure 3 (see legend), in the presence of 10 mM caspase inhibitors. CFU were determined by plating conditions in
quadruplicate on days 0 and 5. Data are representative of three experiments.
(C) rM4s were infected as per the confocal microscopy efferocytosis assay in the presence of 10 mg/ml TIM4 blocking antibody 5G3 or control rat IgG1 and
efferocytosis and secondary infection was enumerated as above. Data are representative of three experiments.
(D) rM4s were infected as in Figure 3 in the presence of aTIM4 or control IgG as indicated and CFU were plated in quadruplicate on days 0 and 6 after infection.
Data are representative of four experiments.
(E) Confocal microscopy efferocytosis assay with infected pM4s as previously described. Uninfected pM4s were pretreated with PGE2 (at the indicated
concentrations) or forskolin (100 mM) for 4 hr prior to washing and addition to the infected pM4 culture. Data are representative of two experiments.
(F) aM4s were infected according to the efferocytosis assay prior to the addition of uninfected aM4s or PGE2-pretreated aM4s. CFUwas determined by plating in
quadruplicate on days 0 and 5 after infection. Data are representative of two experiments.
Error bars indicate ± SEM, p% 0.05, one-way ANOVA with Dunnet’s posttest. See also Figure S2.
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Efferocytosis Is an Antibacterial Mechanismmembrane. PS is a ligand for many efferocytosis receptors and
bridging molecules that aid in apoptotic cell recognition and
engulfment (Fadok et al., 1992; Hoffmann et al., 2001). Resident
peritoneal macrophages rely exclusively on the PS receptor
TIM4 to recognize apoptotic cells and to mediate efferocytosis;
however, TIM4 is not expressed by most other macrophage
subsets (Miyanishi et al., 2007; Rodriguez-Manzanet et al.,
2010). Blocking TIM4 in resident peritoneal macrophages signif-
icantly reduced efferocytosis of Mtb-infected apoptotic cellsCell Host & M(Figure 4C). TIM4 blockade also significantly increased the inci-
dence of secondarily infected cells. This occurs presumably
because the failure to clear apoptotic cells leads to more sec-
ondary necrosis and dispersal of intracellular contents including
Mtb. Importantly, blocking TIM4 reduced the ability of uninfected
macrophages to restrict bacterial growth (Figure 4D). These data
conclusively demonstrate that efferocytosis is an innate anti-
bacterial mechanism as engulfment is specifically required for
control.icrobe 12, 289–300, September 13, 2012 ª2012 Elsevier Inc. 293
Figure 5. Mtb Are Found within Vacuous Efferocytic Phagosomes
along with Cell Debris after Uninfected Macrophage Coculture
(A) Transmission electron micrograph of Mtb (asterisks) within a pM4 stained
with lead citrate (i). Apoptotic thymocytes cocultured with pM4s for 1 hr are
engulfed and retained in phagsomes (ii). Note the three thymocyte apoptotic
blebs in increasing stages of digestion and disintegration.
(B) Mtb within a vacuous efferocytic phagosome inside apoptotic cell blebs
after the coculture of uninfected pM4s with infected pM4s.
PM, plasmamembrane. Scale bars represent 1 mM.White arrows, phagosome
membrane; black arrows, apoptotic bleb membrane. Images are repre-
sentative of two experiments with more than 1,000 M4s examined on multiple
nonserial 60 nM sections.
See also Figure S3.
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Efferocytosis Is an Antibacterial MechanismProinflammatory cytokines and immune mediators such as
TNF and PGE2 have been shown to reduce efferocytosis both
in vitro and in vivo. PGE2 has been previously reported to inhibit
efferocytosis in alveolar macrophages (Aronoff et al., 2004). We
confirmed this finding and found PGE2 also inhibits efferocytosis
in peritoneal macrophages as well, without significantly impact-
ing phagocytosis (Figure S2A). To target the effects of PGE2 on
efferocytic macrophages (and not infected macrophages) unin-
fected macrophages were pre-treated with high doses of PGE2
prior to their addition to infected macrophages. PGE2 inhibited
those macrophages’ ability to engulf Mtb-infected apoptotic
cells as determined by confocal microscopy (Figure 4E). The
inhibitory effect of PGE2 is thought to be mediated by increasing
intracellular cAMP, a crucial regulator of engulfment by phago-
cytes (Rossi et al., 1998). Thus, we showed that forskolin treat-
ment also inhibited efferocytosis (Figure 4E). Importantly, pre-
treatment of uninfected peritoneal macrophages with PGE2
prior to their coculture with infected macrophages limited their
ability to control Mtb growth (Figure S2B). Next, we determined
whether PGE2 could inhibit efferocytosis-mediated control in
alveolar macrophages. PGE2 pretreatment of uninfected alve-
olar macrophages prevented their ability to restrict bacterial
growth in vitro. In several experiments coculture of uninfected
and infected macrophages significantly reduced the number
of recovered bacteria to below the level of the initial inoculums,
which is indicative of bacterial killing, a phenomenon observed
in other studies (Lee et al., 2006) (Figure 4F). These data demon-
strate that efferocytosis is an important innate immune mecha-
nism of bacterial control and is one that can be used by alveolar
macrophages to control Mtb growth or even mediate bacterial
killing.
Mtb and Cell Debris Are Found within Vacuous
Phagosomes after Efferocytosis
Given that efferocytosis of an Mtb-infected apoptotic cell exerts
significant control over Mtb growth, we sought to understand
the unique features of efferocytosis that restrict bacterial
growth. We asked whether the intracellular compartments con-
taining Mtb differed after internalization by phagocytosis versus
efferocytosis. Using transmission electron microscopy (TEM),
we confirmed that 1 day after infection, Mtb was contained
within a tight-fitting phagosome membrane closely juxtaposed
to the bacterial surface, as has been previously seen (van der
Wel et al., 2007) (Figure 5Ai). Mtb were also intact and showed
no sign of degradation. After efferocytosis, apoptotic thymo-
cytes within uninfected macrophages occupied very different
phagosomes (Figure 5Aii). Characteristically, the efferocytic
phagosome is vacuous, with fluid filling the space between
apoptotic cell membrane and phagosome membrane (Vandivier
et al., 2006). Thymocytes, as well as apoptotic macrophages,
were found in various states of digestion and destruction of
both organelle and plasma membranes (Figures 5Aii and S3).
After coculture of Mtb-infected and uninfected macrophages,
Mtb was found within efferocytosed apoptotic blebs encased
within a spacious phagosome (Figure 5B), as well as within large
phagosomes containing apoptotic cell remnants (Figure S3).
Membranes and intact cellular components were discerned
within some of the apoptotic blebs, indicating an early stage of
digestion (Figure 5B). Thus, the efferocytic Mtb phagosome is294 Cell Host & Microbe 12, 289–300, September 13, 2012 ª2012 Elstructurally distinct from a bacterium within a primary infected
macrophage. Damaged Mtb with characteristic ‘‘onion’’
morphology were also observed within vacuous phagosomes
along with cellular debris, possibly indicating killed bacteria after
efferocytosis (Armstrong and Hart, 1971) (Figure S3). This raised
the possibility that bacteria efferocytosed within or among apo-
ptotic cell debris are processed differently than phagocytosed
bacteria.
The Mtb-Efferocytic Phagosome Matures and Acquires
Lysosomal Characteristics
Mtb possesses virulence factors that subvert phagosome
maturation and allow it to exploit the intracellular environmentsevier Inc.
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Figure 6. Efferocytosis Delivers Mtb to the
Lysosome
(A) Mtb within a LAMP1+ vesicle inside an effer-
ocytic CD45.1 BMDM4.
(B) Quantification of (A), percent of Mtb colocaliz-
ing with LAMP1 of total Mtb in primary infected
BMDM4s (clear bar) or CD45.1+ BMDM4s (black
bars). Uninfected CD45.1+ BMDM4s were
untreated, pretreated with PGE2 or added to
infected BMDM4s in the presence of caspase
3 inhibitor. Data are representative of four
experiments.
(C) GFP-H37Rv within Lysotracker Red+ vesicles.
(D) Quantification of (C) showing percent Mtb-
Lysotracker Red colocalization of total GFP-Mtb
in primary infected pM4s or after efferocytosis and
the depicted treatments. Bafilomycin was added at
1 mM for 2 hr before and during Lysotracker
staining. Data are representative of two experi-
ments.
(E) Percent ‘‘live’’ Mtb of total Mtb counted in
primary infected pM4s treated with or without
isoniazid for 24 hr (clear bars). Percent live Mtb in
CD45.1+ macrophages treated with or without
PGE2 before coculture with infected peritoneal
macrophages. Data are representative of two
experiments. Error bars indicate ± SEM, p% 0.05,
one-way ANOVA with Dunnet’s posttest.
(F) ‘‘Live’’ (top) Mtb do not colocalize with LAMP1
as frequently as ‘‘dead’’ (bottom) Mtb in BMDM4s.
(G) Quantification of (F). Percent LAMP1 colocali-
zation with ‘‘live’’ or ‘‘dead’’ Mtb of total Mtb in
BMDM4s. Data are representative of two experi-
ments. Error bars indicate ± SEM, p % 0.05,
Student’s t test.
See also Figure S4.
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Efferocytosis Is an Antibacterial Mechanismof the macrophage (Fratti et al., 2003). We reasoned that the
uptake of Mtb contained within an apoptotic cell further
compartmentalizes Mtb and limits its ability to interfere with
phagosome maturation. To this end, we measured the colocali-
zation of Mtb with markers of mature lysosomes after efferocyto-
sis (Figure 6A). MoreMtbwithin efferocytic bonemarrow-derived
macrophages colocalized with LAMP1 than in primary infected
macrophages (Figure 6B). Inhibiting apoptosis (with a caspase
3 inhibitor) or efferocytosis (with PGE2) both reduced the Mtb-
LAMP1 colocalization back to levels characteristic of primary
infection. The vacuolar ATPase is responsible for maintaining
the acidic pH of the lysosomal compartment is excluded from
Mtb-containing phagosomes (Sturgill-Koszycki et al., 1994).
After efferocytosis, there was greater Mtb-vATPase co-localiza-Cell Host & Microbe 12, 289–300, Setion in efferocytic macrophages than in
primary infected M4s (Figure S4A). Ulti-
mately, low pH marks a functional,
mature lysosome. While the Mtb-contain-
ing phagosome limits acidification, more
Mtb were detected within acidic com-
partments after efferocytosis (Figures 6C
and 6D). Many bacteria were within
large acidified vesicles, reminiscent of
the vacuous efferocytic phagosomes ob-
served by confocal and electron micros-copy. Blocking efferocytosis reduced the bacteria’s colocaliza-
tion with acidic compartments to levels seen in primary
infection. Components of the autophagic machinery have been
implicated in facilitating phagosome maturation, efferocytic
phagosome maturation, and Mtb control (Gutierrez et al., 2004;
Martinez et al., 2011; Sanjuan et al., 2007). However, no specific
enrichment of LC3, an early marker of autophagosomes, was
found on Mtb-containing phagosomes after efferocytosis
(Figure S4B). The fusion of lysosomes with the efferocytic
phagosome delivers catabolic enzymes capable of destroying
the bacterium. These data demonstrate that Mtb is unable to
inhibit maturation of the efferocytic phagosome, exposing
the bacterium to the caustic environment of degradative
lysosomes.ptember 13, 2012 ª2012 Elsevier Inc. 295
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Figure 7. Efferocytosis Controls Mtb In Vivo
(A) Mtb is less viable after efferocytosis in vivo. Live/Dead-H37Rv 5LO/-
infected pM4s were intraperitoneally transferred into CD45.1 mice with IgG or
aTIM4 antibody. Sixteen hours later, cells were removed and treated with
200 ng/ml anhydrous tetracycline to induce GFP expression. Mtb viability was
ascertained by measuring the ratio of GFP:mCherry expression for each
bacterium. ‘‘Input’’ is expression in untransferred infected pM4s. Data are
representative of two experiments. Median, p% 0.001. Mann-Whitney test.
(B) Bacterial burden in spleen and lung of Rag/ mice 2 weeks after intra-
venous transfer of H37Rv-infected 5LO/ pM4s and intraperitoneal admin-
istration of IgG or aTIM4. Data are representative of one experiment. Error bars
indicate ± SEM, p% 0.001, Student’s t test.
See also Figure S5.
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To determine the effect of efferocytosis on bacterial viability at
the single-cell level, we infected macrophages with H37Rv that
constitutively express mCherry (red) and inducibly express
GFP (green) using a TetON promoter. After tetracycline induction
‘‘live’’ bacteria expressed both red and green fluorescent pro-
teins, while bacteria that are dead only fluoresce red. We
confirmed that changes in viability observed with the Live/
Dead reporter Mtb correlate with changes in CFU (Figure S4C).
Using these Live/Dead reporter Mtb, we find that fewer live or
transcriptionally active Mtb were present within efferocytic
macrophages (Figure 6E). We also found that the majority of
the dead bacteria were found within LAMP1+ compartments
(Figures 6F and 6G). Collectively, these data indicate that after
efferocytosis, the efferocytic phagosome containing the infected
apoptotic cell fuses with lysosomes, which are capable of
killing Mtb.
Efferocytosis Controls Mtb In Vivo
Having shown that efferocytosis of Mtb-infected apoptotic
macrophages occurs in vivo (Figure 2), we were next interested
in whether this process contributes to bacterial control in vivo.
We used two approaches to answer this question. First, utilizing
the Live/Dead reporter Mtb, we asked whether efferocytosis kills
Mtb in vivo. 5-lipoxygenase-deficient macrophages (5LO/,
CD45.2) that undergo more apoptosis after infection (Divangahi
et al., 2009) and consequently more efferocytosis (Figure S5),
were infected with Live/Dead-H37Rv and injected intraperitone-
ally into CD45.1mice alongwith aTIM4 or IgG control antibodies.
Sixteen hours later, the peritoneal cavity was lavaged, and the
retrieved cells were plated with tetracycline to induce GFP
expression in the live bacteria. The next day, cells were fixed
and analyzed by microscopy. The viability of Mtb detected in
the transferred (e.g., CD45.2) macrophages was not affected
by the antibody treatment and was similar to Mtb in ‘‘input’’
macrophages that were exclusively cultured in vitro (Figure 7A).
In contrast, the recipient CD45.1 macrophages from mice
treated with IgG contained significantly fewer ‘‘live’’ Mtb (as indi-
cated by a low GFP:mCherry signal) compared with recipient
CD45.1 macrophages from mice treated with TIM4 blocking
antibody (Figure 7A). The former condition (‘‘IgG’’) is enriched
for recipient macrophages that had engulfed Mtb-infected
macrophages. In the latter condition, aTIM4 prevents the
efferocytosis of apoptotic CD45.2 macrophages. Consequently,
thesemacrophages die by secondary necrosis, and the released
bacteria secondarily infect peritoneal macrophages. The
bacteria in the secondarily infected macrophages have the
same viability as Mtb in the input cells. Thus efferocytosis can
kill Mtb in vivo and secondary necrosis is a mechanism of Mtb
spread.
Next we asked whether efferocytosis could control bacterial
burden in vivo. Efferocytosis is highly redundant and thus target-
ing a single efferocytic receptor for blockade in vivo presents
many challenges. TIM4 is an efferocytic receptor responsible
for apoptotic cell uptake on only a minority of macrophages,
but we confirmed previous reports that intraperitoneal adminis-
tration of TIM4 blocking antibody reduces efferocytosis of
CFSE-labeled apoptotic macrophages in the spleen 2–3 hr after
intravenous transfer (Figure S5) (Albacker et al., 2010). Rag/296 Cell Host & Microbe 12, 289–300, September 13, 2012 ª2012 Elrecipient mice were administered aTIM4 or IgG by the intraperi-
toneal route and 5LO/ H37Rv-infected macrophages were
injected intravenously. Two weeks later, we found a significantly
higher Mtb burden in both the spleen and lungs of aTIM4-treated
mice (Figure 7B). Efferocytosis is therefore a protective innate
antibacterial effector mechanism that contributes to control of
Mycobacterium tuberculosis.
DISCUSSION
Apoptosis is thought to be an innate antimycobacterial mecha-
nism. Wild-type (virulent) Mtb are believed to actively inhibit
apoptosis and instead induce necrosis. This idea is based on
the finding that attenuated mutants of Mtb induce greatersevier Inc.
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together with studies on host factors such as eicosanoids that
modulate the death modality of Mtb infected macrophages,
has led to the paradigm that proapoptotic conditions restrict
bacterial replication, while pronecrotic conditions favor bacterial
dispersal, infection of new cells, and bacterial growth (Chen
et al., 2008; Divangahi et al., 2009). However, there is little
evidence that apoptosis has direct antibacterial activity, and
a specific mechanism for apoptosis-induced Mtb death has
never been named. Thus, we hypothesized that cellular events
after apoptosis might be crucial for bacterial control. Efferocyto-
sis is a crucial function of macrophages, but its role during infec-
tion has not been systematically addressed. We sought to test
the hypothesis that efferocytosis of Mtb-infected apoptotic cells
is a cellular mechanism that limits intracellular bacterial
replication.
We found that Mtb-infected apoptotic macrophages are en-
gulfed by surrounding uninfected macrophages both in vitro
and in vivo. Blocking the engulfment of Mtb-infected apoptotic
macrophages, whether by increasing cAMP levels or specifically
blocking the PS receptor TIM4, prevented Mtb control. We do
not believe that these effects are limited to TIM4-mediated
recognition and uptake of apoptotic infected macrophages.
Since themajority of resident peritoneal macrophages rely exclu-
sively on TIM4 as the dominant PS receptor, the use of resident
peritoneal macrophages provided a model that could be used to
study the consequences of inhibiting efferocytosis (Ghosn et al.,
2010). We previously reported that PGE2 protects Mtb-infected
macrophages from necrotic cell death in a cAMP-dependent
fashion (Chen et al., 2008). Clearly, PGE2-cAMP signaling has
many effects. We have shown here that efferocytosis plays
a major role in suppressing bacterial growth after apoptosis.
Indeed, the phenomenon of uninfected macrophages con-
tributing to the control of intracellular mycobacteria after apo-
ptosis was observed over a decade ago (Fratazzi et al., 1997).
At that time, it was speculated that engulfment of apoptotic
infected macrophages could be responsible for bacterial
control. Our current study provides a mechanistic basis for this
observation.
Presumably, there is a basal level of efferocytosis occurring all
the time during culture of macrophages. As efferocytosis is
a constitutive process, many of the phenomenon previously
attributed solely to apoptosis, may in fact require efferocytosis.
The assay system developed here will be an important tool to
study how efferocytosis is regulated (or subverted) in the context
of infection. Our data do not exclude the possibility of other cell
contact and noncontactmechanisms of bacterial control exerted
by uninfected macrophages (Hartman and Kornfeld, 2011). In
fact, in the recent study by Hartman and Kornfeld, efferocytosis
appeared to be inhibited and, in the context of our results, may
indicate that high-MOI nonapoptotic cell death inhibits efferocy-
tosis or prevents the expression of relevant ‘‘eat me’’ signals on
the dying cell.
Mtb exerts tremendous control over the host macrophage
from the relative safety of an arrested phagosome. The bacte-
ria’s ability to impair phagolysosome maturation is a major part
of its virulence strategy; however, how the bacteria accom-
plishes this is still largely unknown. In contrast, it appears that
Mtb is no longer able to inhibit phagolysosome maturationCell Host & Mwhen contained in an efferocytic phagosome and is shuttled to
lysosomes. We envision that this is an issue of compartmentali-
zation: Mtb encased within an apoptotic cell, within an effero-
cytic phagosome, has at least one additional layer of membrane
distancing itself from the host cytosol. We were unable to deter-
mine whether the phagosome membrane from the primary in-
fected macrophage still surrounds Mtb within the efferocytic
phagosome. There is evidence that Mtb translocation to the
cytosol induces cell death, thus perhaps Mtb is only behind
one and not two additional layers of membrane within the effer-
ocytic phagosome (van der Wel et al., 2007). Regardless, Mtb
packaged behind this additional membrane layer cannot inhibit
phagosome maturation and is thus killed. Several studies sug-
gest that Mtbmust be in contact with the phagosomemembrane
in order to inhibit lysosome fusion. Mtb might require close
proximity to the phagosome membrane to efficiently direct its
effector molecules to host cell targets to halt phagolysosome
fusion or to induce cell death (de Chastellier et al., 2009). Or,
simply, the bioactive lipids displayed on Mtb’s cell wall can’t
find their targets behind an additional membrane (Chua et al.,
2004). Additional study is required to ascertain what property
of efferocytosis allows for phagosome maturation.
This report has focused on the role of macrophage apoptosis
as an innate response after Mtb infection. However, the killing of
infected cells is an important arm of the adaptive immune
response to tuberculosis (Woodworth et al., 2008). T cells can
induce apoptotic death in target cells via the release of cytotoxic
granules containing granzymes or through the engagement of
surface receptors containing death domains such as CD95/
95L (Lavrik and Krammer, 2012; Trapani, 2012). We envision
the capacity of CTL to kill infected cells restricts bacterial growth
via apoptosis induction followed by their engulfment by unin-
fected macrophages recruited to inflammatory foci.
The relative efficiency of efferocytosis will depend on the
microenvironment. Some inflammatory signals, such as abun-
dant TNF or PGE2, can impair efferocytosis (Aronoff et al.,
2004; Michlewska et al., 2009). This could lead to greater
secondary necrosis. If efferocytosis is inhibited during active
Mtb infection, pharmacologically releasing this inhibition could
benefit the infected individual in two ways. First, tuberculosis is
a disease of rampant cell death, inflammation and tissue
destruction. Efferocytosis would be key in maintaining proper
lung tissue architecture during disease andminimizing the devel-
opment of immunopathology. Second, enhancing efferocytosis
would restrict bacterial replication and could prevent recrudes-
cence of infection. Additionally, the role of efferocytosis during
the maintenance of latency is completely unknown and might
play an important role during this stage of disease.
Some pathogensmay to subvert efferocytosis to evade immu-
nity. For example, Leishmania employ neutrophil apoptosis and
subsequent efferocytosis as a mechanism of establishing infec-
tion within macrophages (Peters et al., 2008; van Zandbergen
et al., 2004). Indeed, some pathogens might rely on uptake of
infected dying cells to spread the infection, as is the case in
M. marinum infection of zebrafish embryos (Davis and Ramak-
rishnan, 2009). Efferocytosis may control or exacerbate many
infectious diseases and it will be important to explore how
macrophages contribute to microbial immunity by executing
this vital ‘‘house-keeping’’ function.icrobe 12, 289–300, September 13, 2012 ª2012 Elsevier Inc. 297
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Mice and Macrophage Isolation
C57Bl/6 (CD45.2), B6.SJL-Ptprca Pepcb/BoyJ (CD45.1), and B6.129S7-
Rag1tm1Mom/J (Rag/) mice were purchased from Jackson Laboratories
(Bar Harbor, ME) and were kept and bred using standard humane animal
husbandry protocols. All animal experiments were performed in accordance
with relevant guidelines for the care and handling of laboratory animals and
were approved by the Dana Farber Cancer Institute Animal Care and Use
Committee (Animal Welfare Assurance number A3023-01) under Public Health
Service assurance of Office of Laboratory Animal Welfare guidelines. The
animals were housed in Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC)-approved animal facilities. Mtb-infected
mice were housed under BSL3 conditions. Thioglycollate-elicited peritoneal
M4s (pM4s) were lavaged from peritoneal cavities 4–5 days after 3% IP thio-
glycollate injection. M4s were isolated with CD11b microbeads and magnetic
columns (Miltenyi Biotec) and cultured in 24- or 96-well dishes overnight prior
to infection. Resident peritoneal M4s (rM4s) were lavaged from peritoneal
cavities and selected based on CD11b+CD19. Bone marrow M4s (BMM4s)
were differentiated from bone marrow cells 7–10 days in RPMI supplemented
with 20% L929 cell supernatant. Alveolar M4s (aM4s) were lavaged from the
lungs of mice with PBS. Primary human peripheral blood (Research Blood
Components, Boston, MA) monocyte-derived macrophages (MDM4s) were
generated from adherent bead-selected CD14+ selected cells after 7 day
culture with human serum.
Mtb Culture and Infection
mCherry-H37Rv and Live/Dead-H37Rv were cultured with 0.5 mg/ml Hygrom-
ycin B. M4s were grown in 96-well plates and infected at aMOI of 10:1 for 4 hr.
Cultures were then washed three to five times. Efferocytic M4s were added at
two times the number of infected M4s. As indicated efferocytic M4s were pre-
treatedwith 1–10 mMPGE2 (Cayman Chemical) for 4 hr at 37
Cbefore washing
and addition to infected M4s. Caspase inhibitors (10 mM, Calbiochem), aTIM4
(10 mg/ml, a kind gift from Vijay Kuchroo, Harvard Medical School) or rat IgG1
(10 mg/ml) were added after infection. CFU were determined immediately after
infection and at the indicated time points per condition in quadruplicate by
removing culture supernatant, lysing M4s with 1% TritonX/PBS solution,
plating serial dilutions on 7H11 plates and incubating at 37C/5% CO2 for
3 weeks.
Assays for Cell Death
Apoptosis was assessed by TUNEL (Roche) according to the manufacturer’s
specifications on M4s grown on coverglass and fixed with 3.7% paraformal-
dehyde. One hundred infected cells were counted per condition in triplicate
by conventional epifluorescence microscopy with a Nikon TE2000-U inverted
microscopy fitted with a SPOT-RT CCD camera. Apoptosis was scored as
cells possessing a TUNEL+ pyknotic nucleus. Cell Death ELISAPLUS (Roche)
was performed as per the manufacturer’s recommended protocol on
H37Rv-infected macrophages to measure necrosis as was described previ-
ously (Divangahi et al., 2009).
Confocal Microscopy Efferocytosis Assay
M4s from CD45.2 mice were cultured in 24-well dishes in triplicate per con-
dition on coverglass and dyed with Vybrant DiO (Invitrogen) as per the manu-
facturer’s specifications as needed prior to infection with mCherry-H37Rv or
GFP-H37Rv for 4 hr. Bacteria were washed away, and uninfected CD45.1
M4s were added at two times the number of infected M4s. Treatment condi-
tions were added as appropriate. Sixteen to twenty-four hours later, cells were
washed and stained with mouse monoclonal CD45.1 (Abcam) before affixing
to microscopy slides with Prolong Gold plus DAPI (Invitrogen). LAMP1
(Abcam) and LC3 (MBL) staining was done 16–24 hr postinfection after fixation
and TritonX permeabalization. vATPase (Abcam) staining was done 16–24 hr
postinfection after fixation and saponin permeabalization. Lysotracker Red
(Invitrogen) was added 16–24 hr postinfection for 1 hr at 37C at 1 mM prior
to washing and fixation. Tetracycline was added 16 hr after infection/addition
of uninfected M4s at 200 ng/ml and induced GFP expression for 24 hr in Live/
Dead H37Rv-infected M4s. Conditions were analyzed in triplicate, and for
each replicate in each condition 100–300 Mtb were counted. Images were298 Cell Host & Microbe 12, 289–300, September 13, 2012 ª2012 Eltaken with a Nikon TE2000-U inverted microscopy equipped with C1 Plus
confocal laser scanner.
In Vivo Efferocytosis Assays
Microscopy
Adoptive transfer of Mtb-infectedM4swas as described previously (Divangahi
et al., 2009). DiO-dyed CD45.2 pM4s were infected in standing culture with
mCherry-H37Rv for 1 hr. Infected macrophage solution (100 ml) was trans-
ferred into the lungs of uninfected CD45.1 mice via the intratracheal route.
Sixteen to twenty hours later, airway cells were retrieved by bronchoalveolar
lavage, fixed with PFA, stained for CD45.1 and cytospun onto microscopy
slides for confocal microscopy analysis.
Live/Dead
Five million 5LO/ macrophages infected with Live/Dead-H37Rv were in-
jected intraperitoneally into CD45.1 mice along with 400 mg aTIM4 or IgG.
Sixteen hours later, peritoneal cavities were lavaged and cells were plated
onto coverglass in the presence of 200 ng/ml tetracycline. Untransferred
macrophages were similarly plated and tetracycline treated to ascertain base-
line ‘‘input’’ Mtb viability. The next day cells were antibody stained for CD45.1,
paraformaldehyde fixed and examined by confocal microscopy. A ratio of
green (GFP) to red (mCherry) signal was measured for each bacterium.
CFU
H37Rv-infected C57Bl/6 macrophages were IV injected into Rag/ mice
intraperitoneally treated with 400 mg aTIM4 or IgG. Approximately 5 million
macrophages were transferred harboring 100,000 bacteria. Two weeks later,
bacterial burden was assessed in spleen and lung by serial dilution.
Transmission Electron Microscopy
Macrophages were grown in 6-well dishes and infected and treated as
described above. Twenty-four hours after infection cells were fixed with
glutaraldehyde/paraformaldehyde/picric acid in sodium cacodylate buffer for
1 hr. Cells were postfixed for 30 min in Osmium tetroxide/Potassium ferrocy-
anide, washed in water and incubated in uranyl acetate for 30 min. Cells were
washed and dehydraded in alcohol, removed from culture dish in propulene-
oxide, pelleted, and infiltrated for 2 hr in propuleneoxide and TAAB Epon
(Marivac Canada). Samples were embedded in TAAB Epon and polymerized
at 60C for 48 hr. Sections (60 nM) were cut on a Reichert Ultracut-S micro-
tome, picked up onto copper grids, and stained with lead citrate, and were
then examined with a TecnaiG2 Spirit BioTWIN transmission electron micros-
copy and recorded with an AMT 2k CCD camera.
Image Analysis
Microscopy images were analyzed with Image J and colocalization analysis
macros or user-generated pipelines in Cell Profiler (Carpenter et al., 2006).
Investigators were blinded during colocalization analysis.
Statistical Analysis
Statistical analysis and graphical output was done with GraphPad Prism.
One-way ANOVA with Dunnet’s posttest. *p% 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chom.2012.06.010.
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